Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease

Affiliations

• ¹ International Neuroscience Institute, Rudolf-Pichlmayr-Strasse 4, Hannover 30625, Germany.
• ² Department of Clinical and Biological Sciences, University of Torino, Orbassano (TO) 10043, Italy.
• ³ CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, Orbassano (TO) 10043, Italy.
• ⁴ Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY 14642, USA.
• ⁵ Department of Experimental Pain Research, Mannheim Center for Translational Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Mannheim 68167, Germany.
• ⁶ Department of Kidney, Liver and Metabolic Diseases, Children's Hospital, Hannover Medical School, Hannover 30625, Germany.
• ⁷ Ricarda-Huch-Street-10B, Hannover 30880, Germany.
• ⁸ Institute of Molecular and Cell Physiology, Hannover Medical School, Hannover 30625, Germany.
• ⁹ Department of Neuropathology, Institute of Pathology, Hannover Medical School, Hannover 30625, Germany.
• ¹⁰ Institute of Experimental Epileptology and Cognition Research and Department of Epileptology, University Hospital Bonn, Venusberg-Campus 1, Bonn 53127, Germany.